John P. Sabo

Disposition and Biotransformation of the Antiretroviral Drug Nevirapine in Humans

Paul Riska, Michael Lamson, Thomas R. MacGregor et al. · Drug Metabolism and Disposition · 1999 · 221 citations

BI-RG-587 is active against zidovudine-resistant human immunodeficiency virus type 1 and synergistic with zidovudine

D. D. Richman, A. S. Rosenthal, M. T. SKOOG et al. · Antimicrobial Agents and Chemotherapy · 1991 · 157 citations · Full text

Medicinal Chemistry, Antiviral Compound, Medicine +13

Differential Effects of Tipranavir plus Ritonavir on Atorvastatin or Rosuvastatin Pharmacokinetics in Healthy Volunteers

Paul A. Pham, C. J. L. la Porte, Lawrence Lee et al. · Antimicrobial Agents and Chemotherapy · 2009 · 66 citations · Full text

Cardiovascular Pharmacology, Pharmacotherapy, Rosuvastatin Pharmacokinetics +18

Pharmacokinetic Characterization of Different Dose Combinations of Coadministered Tipranavir and Ritonavir in Healthy Volunteers

Thomas R. MacGregor, John P. Sabo, Stephen H. Norris et al. · HIV Clinical Trials · 2004 · 64 citations

Pharmacokinetics of nevirapine and lamivudine in patients with HIV-1 infection

John P. Sabo, Michael Lamson, G Leitz et al. · AAPS PharmSci · 2000 · 63 citations · Full text